<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna Inc. MRNA, +20.57% said Friday it will “rapidly advance” an omicron-specific COVID-19 booster vaccine candidate and continue to work on booster candidates designed to anticipate mutations of the coronavirus and to study and test higher booster doses also meant to boost immunity. The World Health Organization’s technical advisory group earlier on Friday assigned the variant, which was first reported in South Africa, the Greek letter omicron, and said it has been designated a “variant of concern.
...read full article on Market Watch
